Therapeutic potential nesiritide (recombinant b-type natriuretic peptide) in the treatment of heart failure

Expert Opinion on Investigational Drugs

Volumn 8, Issue 7, 1999, Pages 1063-1072

  Hobbs, R E ^a   Mills, R M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Congestive heart failure; Diuretics; Natriuretic peptides; Vasodilators

Indexed keywords

BETA ADRENERGIC RECEPTOR; BRAIN NATRIURETIC PEPTIDE; NESIRITIDE; UNCLASSIFIED DRUG;

ANXIETY; BRADYCARDIA; CHEMICAL STRUCTURE; CLINICAL TRIAL; CONFUSION; CONGESTIVE HEART FAILURE; DRUG EFFICACY; DRUG HALF LIFE; ELECTRIC POTENTIAL; HEART OUTPUT; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOTENSION; HYPOXEMIA; INSOMNIA; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; LUNG CAPILLARY PRESSURE; META ANALYSIS; NAUSEA; NERVOUSNESS; OLIGURIA; REVIEW; SWEATING; TACHYPHYLAXIS;

EID: 0032790904     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.8.7.1063     Document Type: Review

References (37)